Atara Biotherapeutics Inc (ATRA)
10.61
-0.07
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
10.60
-0.01
(-0.09%)
After-Hours: 20:00
Atara Biotherapeutics Profit Margin (Quarterly): -54.51% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -54.51% |
| June 30, 2024 | -66.51% |
| March 31, 2024 | -116.1% |
| December 31, 2023 | -1.42K% |
| September 30, 2023 | -3.26K% |
| June 30, 2023 | -7.43K% |
| March 31, 2023 | -6.10K% |
| December 31, 2022 | -33.74K% |
| Date | Value |
|---|---|
| September 30, 2022 | -1.89K% |
| June 30, 2022 | 35.80% |
| March 31, 2022 | -1.20K% |
| December 31, 2021 | -1.24K% |
| September 30, 2021 | -1.58K% |
| June 30, 2021 | -2.17K% |
| March 31, 2021 | -2.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-33.74K%
Minimum
Dec 2022
35.80%
Maximum
Jun 2022
-4.16K%
Average
-1.58K%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Azenta Inc | -2.93% |
| Perspective Therapeutics Inc | -- |
| Corvus Pharmaceuticals Inc | -- |
| Clearside Biomedical Inc | -740.7% |
| Quanterix Corp | -27.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -85.41% |
| Gross Profit Margin (Quarterly) | 81.08% |
| Operating Margin (Quarterly) | -54.14% |
| Return on Net Operating Assets | -160.3% |